A Cisplatin-Incorporated Liposome That Targets the Epidermal Growth Factor Receptor Enhances Radiotherapeutic Efficacy Without Nephrotoxicity

International Journal of Oncology - Greece
doi 10.3892/ijo.2014.2806

Related search